Keenova Therapeutics

GOLDENTREE ASSET MANAGEMENT LP (10% owner) bought 295,716 Keenova Therapeutics plc at $89.25, worth $26.4M

Form 4 on Keenova Therapeutics, filed with the SEC on Nov 9, 2026, 5:30 pm ET. Source: the filing on SEC EDGAR.

Form
4
Filed
Importance
Major
  1. 145,716 ordinary shares acquired on Nov 5, 2026
  2. 150,000 ordinary shares acquired on Nov 6, 2026
  3. Total owned shares: 8,875,543

Written from the Form 4 on EDGAR. AI can make mistakes. Check the filing.

Get an email when Keenova Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Data on this page was fetched . The filing on SEC.gov is the record.